Literature DB >> 6680223

A new isoeffect curve for change in dose per fraction.

H R Withers, H D Thames, L J Peters.   

Abstract

A method is proposed for using survival curve parameters for calculating the change in total dose necessary to achieve an equal response in a tissue when the dose per fraction is varied. The method uses the ratio alpha/beta of the coefficients of the linear quadratic survival formula and accounts only for the effect of repair of cellular injury. Absolute values for alpha and beta are not required. The isoeffect curves vary for different tissues. A dose adjustment to account for differences in the regeneration of surviving cells that might result from changing a treatment regimen must be made separately and will also vary from tissue to tissue. Examples of the use of the curves are given. At present, the curves, particularly those for late effects, are uncertain and caution should be observed in using them until they are defined more accurately with additional data.

Mesh:

Year:  1983        PMID: 6680223     DOI: 10.1016/s0167-8140(83)80021-8

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  50 in total

1.  Comparison of isoeffect relationships in radiotherapy.

Authors:  E O Voit; P N Yi
Journal:  Bull Math Biol       Date:  1990       Impact factor: 1.758

Review 2.  Studies of the dose-effect relation.

Authors:  A M Kellerer
Journal:  Experientia       Date:  1989-01-15

3.  Radiation therapy for primary carcinoma of the extrahepatic biliary system. An analysis of 63 cases.

Authors:  J C Flickinger; A H Epstein; S Iwatsuki; B I Carr; T E Starzl
Journal:  Cancer       Date:  1991-07-15       Impact factor: 6.860

Review 4.  Linear quadratic and tumour control probability modelling in external beam radiotherapy.

Authors:  S F C O'Rourke; H McAneney; T Hillen
Journal:  J Math Biol       Date:  2008-09-30       Impact factor: 2.259

5.  Redefining relative biological effectiveness in the context of the EQDX formalism: implications for alpha-particle emitter therapy.

Authors:  Robert F Hobbs; Roger W Howell; Hong Song; Sébastien Baechler; George Sgouros
Journal:  Radiat Res       Date:  2014-01       Impact factor: 2.841

Review 6.  Historical essentials influencing the development of radiooncology in the past 100 years.

Authors:  S Birkenhake; R Sauer
Journal:  Experientia       Date:  1995-07-14

7.  Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study.

Authors:  Gabriella Macchia; Savino Cilla; Francesco Deodato; Francesco Legge; Aida Di Stefano; Vito Chiantera; Giovanni Scambia; Vincenzo Valentini; Alessio G Morganti; Gabriella Ferrandina
Journal:  Br J Radiol       Date:  2015-09-21       Impact factor: 3.039

8.  [Prognostic factors and the effect of radiotherapy in the treatment of differentiated thyroid carcinomas].

Authors:  I A Adamietz; M S Schiemann; J G Petkauskas; F Schemmann; H D Böttcher
Journal:  Strahlenther Onkol       Date:  1998-12       Impact factor: 3.621

9.  Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis.

Authors:  Byung Ock Choi; Ihl Bohng Choi; Hong Seok Jang; Young Nam Kang; Ji Sun Jang; Si Hyun Bae; Seung Kew Yoon; Gyu Young Chai; Ki Mun Kang
Journal:  BMC Cancer       Date:  2008-11-27       Impact factor: 4.430

10.  Accelerated hypofractionated radiotherapy as adjuvant regimen after conserving surgery for early breast cancer: interim report of toxicity after a minimum follow up of 3 years.

Authors:  Paola Pinnarò; Antonella Soriani; Valeria Landoni; Carolina Giordano; Maria Papale; Annelisa Marsella; Laura Marucci; Giorgio Arcangeli; Lidia Strigari
Journal:  J Exp Clin Cancer Res       Date:  2010-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.